Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
February 10, 2022 16:05 ET
|
Sensus Healthcare, Inc.
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference...
Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions
January 31, 2022 16:05 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...
Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022
January 26, 2022 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...
Sensus Healthcare to Present at the H.C. Wainwright BioConnect Virtual Conference
January 06, 2022 13:08 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla. , Jan. 06, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference
January 05, 2022 08:00 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Sensus Healthcare Signs Exclusive U.S. Distribution Agreement with Mattioli Eng. Italia for its TransDermal Infusion System
December 01, 2021 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Sensus Healthcare Reports Third Quarter 2021 Financial Results
November 04, 2021 16:02 ET
|
Sensus Healthcare, Inc.
Achieves profitability on revenues of $5.5 million, up sharply from $1.6 million a year ago Affirms expectations for continued growth in 4Q and full-year profitability Conference call begins at 4:30...
Sensus Healthcare to Host Third Quarter 2021 Financial Results and Business Update Conference Call on November 4, 2021
October 20, 2021 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...
Sensus Healthcare to Participate in Fireside Chat Hosted by Maxim Group and M-Vest
October 15, 2021 08:30 ET
|
Sensus Healthcare, Inc.
BOCA RATON, Fla, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...
Chinese Health Authority Renews License for Sensus Healthcare’s SRT-100™ for Five More Years
October 12, 2021 08:30 ET
|
Sensus Healthcare, Inc.
Third Renewal for System to Treat Non-melanoma Skin Cancer and Keloids Across Greater China BOCA RATON, Fla., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a...